Skip to main content


Dr Al-Jamal’s team focuses on engineering novel nanomaterials for biomedical applications. She has a multidisciplinary team, who are working on developing novel nanomedicines for combinatory therapy and theranostic applications.

To design and develop smart (stimuli-responsive) vectors to improve gene and anticancer therapy, besides introducing new targeting approaches to enhance efficacy and to reduce side effects of existing chemotherapeutics.

Explore new methodologies, such as microfluidics, to fabricate and scale up multifunctional nanoparticles for combinatory therapy or theranostic applications.


Find out more



I am always open to PhD applications in the field of nanopharmaceutical, targeted delivery, smart and novel nanomaterials, exosomes, immunotherapy, tumour microenvironment, and nanotoxicology.


Make a PhD enquiry



School of Pharmacy

Wafa Al-Jamal

Dr Al-Jamal is an overseas and a UK-registered pharmacist. She completed her PhD in Nanotechnology and Drug Delivery from London School of Pharmacy (now known as UCL School of Pharmacy), then she worked at UCL School of Pharmacy and King’s College London, as a Senior Research Fellow in the field of Cancer Nanomedicine (2008-2013). She joined the University of East Anglia, Norwich, as a Lecturer in Nanomedicine and Drug Delivery (2013-2017), before starting at Queen’s University Belfast as a Reader in Nanomedicine. 



Research students

PhD Title: Preparation of Multifunctional Nanoparticles Using Microfluidics

Name: Calvin Cheung
Years of Study: 2016-2019
Country: UK

PhD Title: Novel Multifunctional Nanoparticles for Advanced Prostate Cancer

Name: Cédrik-Roland Koffi
Years of Study: 2016-2019
Country: France


PhD Title: Designing Nanomedicine-Based Therapeutics for Advanced Prostate Cancer

Name: Sara Pereira
Years of Study: 2016-2019
Country: Portugal

PhD Title: Engineering PSMA-targeted exosome-like vesicles to target prostate cancer metastasis

Name: Maja Severic
Years of Study: 2016-2019
Country: Croatia

Alumni: where are they now?

Dr Mei Kuo-Ching

MRes Thesis Title: Engineering Triggerable Liposome-Nanoparticle Hybrids as Novel Multifunctional Drug Delivery System (Distinction)

Years of Study: 2010-2011
Country: Taiwan
Current position: Mei is a fourth year PhD student at King’s College London. He received the Graduate School International Research Award (GSIR) from King’s College to work on the development of carbon nanostructures-based multimodal delivery systems for brain targeting. 

Dr Raphael Egbu

MSc Thesis Title: Optimizing the encapsulation of docetaxel anti-cancer drug in liposomal formulations (Distinction)

Years of Study: 2014-2015
Country: UK
Current position: Raphael is a second year PhD student at University College London. Received a studentship from Centre for Doctoral Training in Advanced Therapeutics and Nanomedicines (UCL) to focus on stabilising polypeptide and protein therapeutics.

Dr Duuamene Nyimanu

MSc thesis Title: Assessing the in vitro Cytotoxicity of Tirapazamine in a Three-dimensional Spheroid Model of Prostate Cancer (Distinction).

Years of Study: 2014-2015
Country: Nigeria
Current position: Duuamene is a second year PhD student at Cambridge University. He is working on designing modified Elabela peptides to treat patients with pulmonary hypertension.

Research at Queen's

Postgraduate research

Start your application

Apply now
graduate school interior

Postgraduate Experience

The Graduate School

Our dedicated hub for postgraduate students, providing state-of-the-art facilities for study, and high-quality training and development programmes within a diverse interdisciplinary community.

The gateway to your postgraduate experience